We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+14.5%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$59B
AUM Growth
+$9.67B
Cap. Flow
+$3.02B
Cap. Flow %
5.11%
Top 10 Hldgs %
26.45%
Holding
2,790
New
663
Increased
538
Reduced
776
Closed
680

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$905M
2
NVDA icon
NVIDIA
NVDA
+$592M
3
AMD icon
Advanced Micro Devices
AMD
+$439M
4
AMGN icon
Amgen
AMGN
+$385M
5
ADBE icon
Adobe
ADBE
+$382M

Sector Composition

Rank Sector Weight
1 Technology 14.79%
2 Consumer Discretionary 13.23%
3 Healthcare 12.61%
4 Financials 7.44%
5 Communication Services 6.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REX icon
1076
REX American Resources
REX
$1.44B
$2.78M ﹤0.01%
+117,574
New +$2.35M
PDM
1077
Piedmont Realty Trust
PDM
$1.22B
$2.78M ﹤0.01%
+390,757
New +$2.36M
NUS icon
1078
Nu Skin
NUS
$250M
$2.77M ﹤0.01%
142,483
-888,841
-86% -$16.4M
AZN icon
1079
AstraZeneca
AZN
$263B
$2.75M ﹤0.01%
20,387
+4,186
+26% +$544K
PPYAW
1080
CALL
DELISTED
Papaya Growth Opportunity Corp. I Warrant
PPYAW
$2.73M ﹤0.01%
239,211
-10,788
-4% -$183
PGNY icon
1081
Progyny
PGNY
$2.47B
$2.72M ﹤0.01%
73,091
-560,433
-88% -$18.8M
VLTO icon
1082
Veralto
VLTO
$23.2B
$2.71M ﹤0.01%
+32,973
New +$2.46M
MITK icon
1083
Mitek Systems
MITK
$768M
$2.71M ﹤0.01%
207,671
-109,969
-35% -$1.23M
POST icon
1084
Post Holdings
POST
$4.14B
$2.71M ﹤0.01%
30,730
-67,567
-69% -$5.74M
BDX icon
1085
Becton Dickinson
BDX
$43.8B
$2.7M ﹤0.01%
11,093
-192,171
-95% -$47.4M
INCY icon
1086
Incyte
INCY
$23.7B
$2.68M ﹤0.01%
42,659
-546,865
-93% -$30.9M
NAT icon
1087
Nordic American Tanker
NAT
$1.37B
$2.67M ﹤0.01%
635,632
-4,400,796
-87% -$18.7M
TGLS icon
1088
Tecnoglass
TGLS
$2.01B
$2.67M ﹤0.01%
58,400
-601,378
-91% -$21.7M
LFMD icon
1089
LifeMD
LFMD
$187M
$2.67M ﹤0.01%
321,891
-106,695
-25% -$767K
HLT icon
1090
Hilton Worldwide
HLT
$75.3B
$2.66M ﹤0.01%
+14,610
New +$2.38M
ROIV icon
1091
Roivant Sciences
ROIV
$25B
$2.66M ﹤0.01%
+236,843
New +$2.31M
PYPL icon
1092
CALL
PayPal
PYPL
$49.5B
$2.64M ﹤0.01%
+43,000
New +$2.46M
CLW icon
1093
Clearwater Paper
CLW
$278M
$2.63M ﹤0.01%
72,899
+26,735
+58% +$960K
MBC icon
1094
MasterBrand
MBC
$1.12B
$2.63M ﹤0.01%
176,982
-888,949
-83% -$11.4M
VOD icon
1095
Vodafone
VOD
$36.4B
$2.63M ﹤0.01%
301,804
-3,578,869
-92% -$32.7M
CPB icon
1096
Campbell Soup
CPB
$6.67B
$2.62M ﹤0.01%
+60,709
New +$2.5M
UTI icon
1097
Universal Technical Institute
UTI
$2.12B
$2.61M ﹤0.01%
+208,744
New +$2.12M
FHI icon
1098
Federated Hermes
FHI
$4.5B
$2.61M ﹤0.01%
77,000
+23,300
+43% +$759K
CCK icon
1099
Crown Holdings
CCK
$12.9B
$2.59M ﹤0.01%
+28,114
New +$2.38M
OCAXW
1100
CALL
DELISTED
OCA Acquisition Corp. Warrant
OCAXW
$2.58M ﹤0.01%
238,968

Similar funds

Marshall Wace's Q4 2023 Portfolio in Review

As of Q4 2023, Marshall Wace held 2,790 positions worth $59B, up 20% from $49.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Marshall Wace deployed $3.02B of net new capital in Q4 2023, opening 663 new positions and adding to 538 existing holdings. Its largest new stake was Qualcomm: 1,674,985 shares worth $242M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Microsoft, an estimated $905M trimmed.

  • Marshall Wace's largest Q4 2023 buy was Qualcomm: 1,674,985 shares worth $242M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $3.43B increase.
  • Marshall Wace's biggest Q4 2023 reduction was Microsoft, cutting an estimated $905M.
  • Marshall Wace fully exited VMware, Inc in Q4 2023, selling an estimated $149M.
  • Marshall Wace's ten largest holdings make up 26% of its $59B portfolio in Q4 2023.
  • Marshall Wace opened 663 new positions and closed 680 in Q4 2023.
  • Marshall Wace's portfolio value rose 20% quarter-over-quarter to $59B.

Based on Marshall Wace's 13F filing for Q4 2023, filed 14 Feb 2024.